West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc. (WPS)

Market Closed
20 Jun, 20:00
191. 55
-0.5
-0.26%
- Market Cap
49.01 P/E Ratio
0.8% Div Yield
0 Volume
7.62 Eps
192.05
Previous Close
Day Range
191.55 191.55
Year Range
174.55 332.1
Earnings results expected in 32 days

Summary

WPS closed today lower at €191.55, a decrease of 0.26% from yesterday's close, completing a monthly increase of 1.7% or €3.2. Over the past 12 months, WPS stock lost -39.4%.
WPS pays dividends to its shareholders, with the most recent payment made on May 07, 2025. The next announced payment will be in In 1 month on Aug 06, 2025 for a total of €0.21.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.15%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track WPS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

WPS Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit

WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit

NEW YORK , June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Prnewswire | 10 hours ago
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit.

Prnewswire | 12 hours ago
WST DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

WST DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.

Globenewswire | 13 hours ago

West Pharmaceutical Services Inc. Dividends

West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 7 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share

West Pharmaceutical Services Inc. Earnings

23 Jul 2025 (32 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS
West Pharmaceutical Services Inc. logo
WST In 1 month
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 1 month ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 4 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 7 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc. logo
WST 10 months ago
Paid
Quarterly
$0.2 Per Share
23 Jul 2025 (32 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS

West Pharmaceutical Services Inc. (WPS) FAQ

What is the stock price today?

The current price is €191.55.

On which exchange is it traded?

West Pharmaceutical Services Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is WPS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has West Pharmaceutical Services Inc. ever had a stock split?

West Pharmaceutical Services Inc. had 0 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Mr. Eric M. Green CEO
XMUN Exchange
US9553061055 ISIN
US Country
10,600 Employees
30 Apr 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Contact Information

Address: 530 Herman O. West Drive
Phone: 610 594 2900